Tag: Upadacitinib

Explore our medication guides and pharmacology articles within this category.

Is Rinvoq a Biologic? Demystifying the Difference Between JAK Inhibitors and Biologics

Oct 5, 2025 •

3 min read

For patients exploring treatment options for inflammatory conditions, a common question arises: Is Rinvoq a biologic? The simple answer is no; Rinvoq is a small-molecule drug, a key distinction from biologics which are complex drugs derived from living sources.

What is upadacitinib, and how does it treat inflammatory conditions?

Oct 5, 2025 •

3 min read

Upadacitinib, a targeted synthetic small-molecule drug, demonstrates significantly higher efficacy than conventional disease-modifying antirheumatic drugs (DMARDs) in treating moderate-to-severe rheumatoid arthritis. This advanced medication, known by the brand name Rinvoq, functions as a Janus kinase (JAK) inhibitor to manage several chronic inflammatory diseases.